CN102188406A - Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride - Google Patents

Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride Download PDF

Info

Publication number
CN102188406A
CN102188406A CN2011101220378A CN201110122037A CN102188406A CN 102188406 A CN102188406 A CN 102188406A CN 2011101220378 A CN2011101220378 A CN 2011101220378A CN 201110122037 A CN201110122037 A CN 201110122037A CN 102188406 A CN102188406 A CN 102188406A
Authority
CN
China
Prior art keywords
solution
levofloxacin hydrochloride
wall material
acrylic resin
taste masking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011101220378A
Other languages
Chinese (zh)
Other versions
CN102188406B (en
Inventor
李强
张士伟
赵学玲
苏玉
张华�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING ZHENGKE PHARMACEUTICAL CO., LTD.
Original Assignee
Heilongjiang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang University filed Critical Heilongjiang University
Priority to CN201110122037.8A priority Critical patent/CN102188406B/en
Publication of CN102188406A publication Critical patent/CN102188406A/en
Application granted granted Critical
Publication of CN102188406B publication Critical patent/CN102188406B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride. The application of the levofloxacin hydrochloride to treating animal diseases is greatly limited by the bitterness of the levofloxacin hydrochloride. The preparation method of the taste-concealing micro-capsules of the levofloxacin hydrochloride comprises steps of dissolving 5% to 90% of the mixture of acrylic resin II or acrylic resin III or acrylic resin II and acylic resin III with 20% of sodium hydroxide solution to prepare 5% to 10% of wall material solution, adjusting the solution into an alkalescent solution, adding distilled water to dissolve levofloxacin hydrochloride to prepare 10% to 40% of core material solution, mixing the wall material solution and the core material solution, adding 0.5% to 5% of Span 80 to prepare 1-10 times of quality of atoleine, carrying out high-shear emulsification and dispersion to the mixture to prepare a stable WxO emulsion type emulsion, stirring the emulsion, dripping hydrochloric acid into the solution to adjust the solution to an acid solution, dissolving the wall material out to cover the surface of capsule core material, and filtering and drying the surface of the capsule core material, and adding a small amount of magnesium aluminum silicate to absorb the residual atoleine. The invention is applied to medicines.

Description

The production method of levofloxacin hydrochloride taste masking microcapsule
Technical field:
Invention relates to a kind of field of medicaments that is used for; Be specifically related to a kind of production method of levofloxacin hydrochloride taste masking microcapsule.
Background technology:
Levofloxacin hydrochloride (Levofloxacin Hydrochloride), have another name called the levofloxacin hydrochlorate, its chemical name is: (S)-(-)-and 9-fluoro-2,3-dihydro-3-methyl isophthalic acid 0-(4-methyl isophthalic acid-piperazinyl)-7-oxygen-7H pyridine benzene a pair of horses going side by side [1,2,3-de]-monohydrate of [1,4] benzene a pair of horses going side by side oxazines-6-carboxylic acid hydrochloric acid, molecular weight is 415.85.Modern pharmacological research proves, levofloxacin hydrochloride belongs to the quinolones extensive pedigree antibiotic, antibacterial action is strong, to most enterobacteriaceae lactobacteriaceaes, stronger antibacterial activity is arranged as gram-negative bacterias such as escherichia coli, Klebsiella, Proteus, Salmonella, Shigella and hemophilus influenza, legionella pneumophilia, Diplococcus gonorrhoeae.Gram positive bacterias such as staphylococcus aureus, streptococcus pneumoniae, micrococcus scarlatinae and mycoplasma pneumoniae, Chlamydia pneumoniae also there is antibacterial action.Can be used for treating diseases such as respiratory system infection, gastrointestinal infection and skin soft-tissue infection clinically.
But the levofloxacin hydrochloride bitter in the mouth adds the grazing rate or the amount of drinking water that can cause animal in feedstuff or the drinking-water to and reduces, and this has just limited the application of levofloxacin hydrochloride in the Animal diseases treatment greatly.
Summary of the invention:
The purpose of invention provides a kind of production method of levofloxacin hydrochloride taste masking microcapsule, to cover the bitterness of levofloxacin hydrochloride, improves the suitability and the palatability of taking.
Above-mentioned purpose realizes by following technical scheme:
A kind of production method of levofloxacin hydrochloride taste masking microcapsule, comprised for six steps: the first step, mixture with acrylic resin II or acrylic resin III or acrylic resin II and acrylic resin III, consumption is 5% ~ 90%, and with the dissolving of 20% sodium hydroxide solution, make 5% ~ 10% wall material solution, be adjusted to alkalescence;
In second step, levofloxacin hydrochloride is as core, and 10% ~ 40% core solution is made in the adding distil water dissolving;
The 3rd step, the first step and the wall material in second step and core solution are mixed, add volume and be 0.5% ~ 5% sorbester p17 after, add the liquid paraffin of 1 ~ 10 times of amount of volume again;
In the 4th step, with the mixed system of the 3rd step gained, high-shear emulsifying disperses, and makes stable water-in-oil emulsion type Emulsion;
In the 5th step, with the Emulsion stirring of the 4th step gained, the dripping hydrochloric acid regulation system is to acid lentamente simultaneously, and the surface of core-clad material is separated out and be coated on to the wall material;
In the 6th step, with the mixed system filtration of the 5th step gained, drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.
The production method of described levofloxacin hydrochloride taste masking microcapsule, the envelop rate of described levofloxacin hydrochloride is greater than 80%.
Beneficial effect:
1. technological operation of the present invention is simple, the envelop rate height, and equipment needed thereby is simple, inexpensive, be easy to get, and production cost is low, and the cycle is short, and the nontoxic and recyclable recycling of solvent for use realizes the zero-emission of producing.
2. gained powder of the present invention has good flowability, dispersibility and palatability, and is difficult for the moisture absorption, has greatly enlarged the range of application of levofloxacin hydrochloride; This product can directly make an addition in animal feed or the drinking-water, does not influence the grazing rate of animal.
3. of the present inventionly can effectively cover the bitterness of levofloxacin hydrochloride, and have good flowability, can mix interpolation, solve an above-mentioned difficult problem, have broad application prospects with any feedstuff.
4. acrylic resin of the present invention is by methacrylic acid and methyl methacrylate copolymerization by a certain percentage and get, be anionic polymer, when pH value greater than 7 time dissolvings, be mainly used in the preparation of enteric coating, slow-release material, microcapsule, the fine and close flexible of good film-forming property, film, the effect that has the moisture resistance effect and improve medicine stability.
5. microcapsule technology of the present invention is as a high and new technology, become various countries scholar's research focus, along with the continuous intensification of people to microcapsule understanding, the continuous appearance of new equipment, new preparation technology and new material, microcapsule technology will cut a conspicuous figure on the development history of human civilization.
6. the acrylic resin safety, nontoxic, the stable in properties that adopt of the present invention, good film-forming property, softgel shell densification; This product operation is simple, the envelop rate height, and equipment needed thereby is simple, inexpensive, be easy to get, and production cost is low, and the cycle is short; The powder of this product gained has good flowability, dispersibility and palatability, and is difficult for the moisture absorption, has greatly enlarged the range of application of levofloxacin hydrochloride.
7. powder of the present invention can directly make an addition in animal feed or the drinking-water, does not influence the grazing rate of animal.
8. solvent used in the present invention is water and liquid paraffin, and is nontoxic, environmentally safe, and can reuse, realize the zero-emission of production, saved production cost greatly, commercial production feasibility height.
The specific embodiment:
Embodiment 1:
1. the production method of a levofloxacin hydrochloride taste masking microcapsule, comprised for six steps: the first step, mixture with acrylic resin II or acrylic resin III or acrylic resin II and acrylic resin III, consumption is 5% ~ 90%, and with the dissolving of 20% sodium hydroxide solution, make 5% ~ 10% wall material solution, be adjusted to alkalescence;
In second step, levofloxacin hydrochloride is as core, and 10% ~ 40% core solution is made in the adding distil water dissolving;
The 3rd step, the first step and the wall material in second step and core solution are mixed, add volume and be 0.5% ~ 5% sorbester p17 after, add the liquid paraffin of 1 ~ 10 times of amount of volume again;
In the 4th step, with the mixed system of the 3rd step gained, high-shear emulsifying disperses, and makes stable water-in-oil emulsion type Emulsion;
In the 5th step, with the Emulsion stirring of the 4th step gained, the dripping hydrochloric acid regulation system is to acid lentamente simultaneously, and the surface of core-clad material is separated out and be coated on to the wall material;
In the 6th step, with the mixed system filtration of the 5th step gained, drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.
Embodiment 2:
The production method of embodiment 1 described levofloxacin hydrochloride taste masking microcapsule, the envelop rate of described levofloxacin hydrochloride is greater than 80%.
Embodiment 3:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, take by weighing acrylic resin II and acrylic resin III (1: 1) and mix wall material 1g, add 20%NaOH solution 10ml, treat that the wall material dissolves fully after, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing the 1g levofloxacin hydrochloride, add 10ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 30ml liquid paraffin of 0.5ml, with 10000rpm emulsifying 1min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking is effective, and particle flow is good, satisfies the invention requirement.
Embodiment 4:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, take by weighing acrylic resin II and acrylic resin III (1: 1) and mix wall material 2 g, add 20% NaOH solution, 15 ml, after treating that the wall material dissolves fully, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 1 g levofloxacin hydrochloride, add 5 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 35 ml liquid paraffin of 0.5 ml, with 14000 rpm emulsifyings, 0.5 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000 rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking is effective, and particle flow is good, satisfies the invention requirement, and envelop rate is up to 89%.
Embodiment 5:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, take by weighing acrylic resin II and acrylic resin III (1: 1) and mix wall material 1 g, add 20% NaOH solution, 10 ml, after treating that the wall material dissolves fully, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 1 g levofloxacin hydrochloride, add 10 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 50 ml liquid paraffin of 1 ml, with 10000 rpm emulsifyings, 1 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000 rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking effect is fine, particle flow sexual satisfaction invention requirement, and envelop rate is up to 95%.
Embodiment 6:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, take by weighing acrylic resin II and acrylic resin III (1: 2) and mix wall material 2 g, add 20% NaOH solution, 15 ml, after treating that the wall material dissolves fully, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 2 g levofloxacin hydrochlorides, add 10 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 100 ml liquid paraffin of 2 ml, with 12000 rpm emulsifyings, 3 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000 rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking effect satisfies the invention requirement, and particle flow is good, and envelop rate is 87%.
Embodiment 7:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, take by weighing acrylic resin II and acrylic resin III (2: 1) and mix wall material 1 g, add 20% NaOH solution, 15 ml, after treating that the wall material dissolves fully, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 2 g levofloxacin hydrochlorides, add 10 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 25 ml liquid paraffin of 1 ml, with 10000 rpm emulsifyings, 2 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000 rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking is respond well, and particle flow is good, satisfies the invention requirement, and envelop rate is 82.6%.
Embodiment 8:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule takes by weighing acrylic resin III 1 g, adds 20% NaOH solution, 8 ml, treat that the wall material dissolves fully after, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 0.5 g levofloxacin hydrochloride, add 10 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 20 ml liquid paraffin of 0.6 ml, with 14000 rpm emulsifyings, 0.5 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue stirring with 1000 rpm and drip dilute hydrochloric acid simultaneously when system is acidity, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking is effective, and particle flow is good, satisfies the invention requirement, and envelop rate is 88%.
Embodiment 9:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule takes by weighing acrylic resin II 1 g, adds 20% NaOH solution, 20 ml, treat that the wall material dissolves fully after, with dilute hydrochloric acid with solution furnishing alkalescence stand-by (wall material solution); Take by weighing 1 g levofloxacin hydrochloride, add 20 ml water it is dissolved fully, with sodium hydroxide solution furnishing alkalescence stand-by (core solution); After wall material solution and the mixing of core solution, add sorbester p17 and the 100 ml liquid paraffin of 1 ml, with 12000 rpm emulsifyings, 4 min, be prepared into stable water-in-oil emulsion type Emulsion; Continue to stir simultaneously dripping hydrochloric acid when system is acidity with 1000 rpm, the wall material begins to separate out, and forms microcapsule, filters, and drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.This levofloxacin hydrochloride taste masking microcapsule taste masking is effective, and particle flow is good, satisfies the invention requirement, and envelop rate is 90%.
Embodiment 10:
The production method of the described levofloxacin hydrochloride taste masking of above embodiment microcapsule, experimental group is fed to tame chicken according to behind the levofloxacin hydrochloride taste masking microcapsule of embodiment 1 preparation and the feedstuff mix homogeneously; Matched group will be suitable with the experimental group drug loading levofloxacin hydrochloride directly with the feedstuff mix homogeneously after hello to matched group man chicken.By contrast grazing rate result, show the experimental group that adds levofloxacin hydrochloride taste masking microcapsule, grazing rate of tame chicken and daily grazing rate be (P>0.05) quite, is much higher than the grazing rate (P<0.05) of control experiment group; Illustrate that levofloxacin hydrochloride taste masking microcapsule has good taste masking performance.

Claims (2)

1. the production method of a levofloxacin hydrochloride taste masking microcapsule, it is characterized in that: the first step, mixture with acrylic resin II or acrylic resin III or acrylic resin II and acrylic resin III, consumption is 5% ~ 90%, and with the dissolving of 20% sodium hydroxide solution, make 5% ~ 10% wall material solution, be adjusted to alkalescence;
In second step, levofloxacin hydrochloride is as core, and 10% ~ 40% core solution is made in the adding distil water dissolving;
The 3rd step, the first step and the wall material in second step and core solution are mixed, add volume and be 0.5% ~ 5% sorbester p17 after, add the liquid paraffin of 1 ~ 10 times of amount of volume again;
In the 4th step, with the mixed system of the 3rd step gained, high-shear emulsifying disperses, and makes stable water-in-oil emulsion type Emulsion;
In the 5th step, with the Emulsion stirring of the 4th step gained, the dripping hydrochloric acid regulation system is to acid lentamente simultaneously, and the surface of core-clad material is separated out and be coated on to the wall material;
In the 6th step, with the mixed system filtration of the 5th step gained, drying adds the residual liquid paraffin of a small amount of Magnesiumaluminumsilicate absorption and promptly gets levofloxacin hydrochloride taste masking microcapsule.
2. the production method of levofloxacin hydrochloride taste masking microcapsule according to claim 1 is characterized in that: the envelop rate of described levofloxacin hydrochloride is greater than 80%.
CN201110122037.8A 2011-05-12 2011-05-12 Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride Active CN102188406B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110122037.8A CN102188406B (en) 2011-05-12 2011-05-12 Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110122037.8A CN102188406B (en) 2011-05-12 2011-05-12 Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride

Publications (2)

Publication Number Publication Date
CN102188406A true CN102188406A (en) 2011-09-21
CN102188406B CN102188406B (en) 2015-02-25

Family

ID=44597846

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110122037.8A Active CN102188406B (en) 2011-05-12 2011-05-12 Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride

Country Status (1)

Country Link
CN (1) CN102188406B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055374A (en) * 2015-09-16 2015-11-18 山西沃德华兽生物技术有限公司 Slow-release type sarafloxacin hydrochloride microcapsule and preparation method thereof
CN108567761A (en) * 2018-07-25 2018-09-25 江苏黄河药业股份有限公司 A kind of Levofloxacin Hydrochloride Capsules and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1878539A (en) * 2003-12-15 2006-12-13 科学与工业研究委员会 Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1878539A (en) * 2003-12-15 2006-12-13 科学与工业研究委员会 Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杜洪建等: "蛋白药物肠溶微囊的制备及药物释放试验", 《中国医院药学杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055374A (en) * 2015-09-16 2015-11-18 山西沃德华兽生物技术有限公司 Slow-release type sarafloxacin hydrochloride microcapsule and preparation method thereof
CN105055374B (en) * 2015-09-16 2017-11-03 山西沃德华兽生物技术有限公司 A kind of spacetabs type hydrochloric acid sarafloxacin microcapsules and preparation method thereof
CN108567761A (en) * 2018-07-25 2018-09-25 江苏黄河药业股份有限公司 A kind of Levofloxacin Hydrochloride Capsules and preparation method thereof

Also Published As

Publication number Publication date
CN102188406B (en) 2015-02-25

Similar Documents

Publication Publication Date Title
CN102240815A (en) Method for preparing nano silver particles by using plant extract for reduction, and application of method
CN102499944B (en) Nanometer silver antibiotic and antiviral compound liquid and its preparation method and products
CN104975513A (en) Efficient antibacterial chitosan essential oil microcapsule preparation method
CN1938004A (en) Tamper resistant dosage form comprising an adsorbent and an adverse agent
CN109430265A (en) The method for preparing carvacrol microcapsule anti-bacterial agent using attapulgite stabilized oil-in-water lotion
CN101744771A (en) Method for preparing solid enrofloxacin nano particles
CN102846655A (en) Formulation and preparation method of antibacterial spray
CN102335196A (en) Use of supported nano zinc oxide as anti-diarrhea agent for weaned pigs and using method
JP2005530863A5 (en)
CN102188406A (en) Preparation method of taste-concealing micro-capsules of levofloxacin hydrochloride
CN101829124B (en) Veterinary compound sulfadiazine sodium injection and preparation method thereof
CN103263476A (en) Composite bacteriostatic agent for reducing irritation
CN107737043A (en) A kind of self-assembled nanometer compound, preparation method and application that Tea Polyphenols is loaded based on hyaluronic acid
JP2004161600A (en) Hollow carrier, functional particle and manufacture method of the same
CN105749293A (en) Oxygen-containing xanthene ketone modified polymer drug as well as preparation method and application thereof in preparation of antibacterial drugs
CN102525952A (en) Method for producing berberine micro-pills
CN103301147A (en) Nanometer compound ceftiofur suspension and preparation method thereof
CN101953882B (en) Compound microcapsule for treating bacterial disease of livestock and poultry and preparation method thereof
CN103922451A (en) Environment-friendly polysilicic acid modified montmorillonite composite running water flocculant
CN106519071A (en) Synthetic method of antitumor drug 6-hydroxy seleninic acid esterification chitosan copper
CN114869850B (en) Cefquinome sulfate injection
CN101664112B (en) Production method of feed colistin sulfate microcapsules
CN104706621A (en) Marbofloxacin micro-capsule and preparation method thereof
CN101716139A (en) Lomefloxacin hydrochloride long-acting slow-release injection solution for livestock and preparation method thereof
CN1180779C (en) Sow-released roxithromycin capsule and method for preparing same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170314

Address after: 150000 Heilongjiang City, Nangang Province, East District, the city of Victoria Street, unit 299, building 2, building 3

Patentee after: Wang Guanhong

Address before: 150080 Harbin, Heilongjiang, Nangang District Road, No. 74

Patentee before: Heilongjiang University

CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Wang Guanhong

Inventor before: Li Qiang

Inventor before: Zhang Shiwei

Inventor before: Zhao Xueling

Inventor before: Su Yu

Inventor before: Zhang Hua

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170322

Address after: 210000 Jiangsu city of Nanjing province Nanjing economic and Technological Development Zone No. 3 Huimeilu

Patentee after: NANJING ZHENGKE PHARMACEUTICAL CO., LTD.

Address before: 150000 Heilongjiang City, Nangang Province, East District, the city of Victoria Street, unit 299, building 2, building 3

Patentee before: Wang Guanhong